Napatree Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.68M Buy
3,379
+122
+4% +$66.1K 0.95% 27
2024
Q4
$1.69M Buy
3,257
+300
+10% +$165K 0.99% 26
2024
Q3
$1.83M Sell
2,957
-53
-2% -$31.4K 1.28% 19
2024
Q2
$1.61M Buy
3,010
+1,075
+56% +$616K 1.31% 19
2024
Q1
$1.1M Hold
1,935
1.07% 23
2023
Q4
$1.03M Buy
+1,935
New +$937K 1.03% 26

Other funds holding TMO

Napatree Capital's TMO Position: Q1 2025 in Review

Napatree Capital increased its Thermo Fisher Scientific (TMO) stake by 3.7% in Q1 2025, buying an estimated $66.1K and bringing the position to 3,379 shares worth $1.68M. The position accounts for 0.95% of the portfolio, ranked #27.

Napatree Capital first reported a position in TMO in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.83M in Q3 2024. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Napatree Capital held 3,379 shares of Thermo Fisher Scientific worth $1.68M as of Q1 2025.
  • Napatree Capital bought 122 Thermo Fisher Scientific shares in Q1 2025, an estimated $66.1K.
  • Thermo Fisher Scientific made up 0.95% of Napatree Capital's portfolio in Q1 2025, its #27 holding.
  • Napatree Capital first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 6 quarters since.
  • Napatree Capital's Thermo Fisher Scientific position peaked at $1.83M in Q3 2024.
  • 2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Napatree Capital's 13F filing for Q1 2025, filed 2 May 2025.